Protaryx Medical announced today that it raised $8.3 million for the development of its first-in-class device for transseptal access to the left atrium. The Baltimore-based company’s funding includes non-dilutive grants and a seed round totaling $3.2 million, along with a recently closed $5.1 million Series A round led by Ajax Health, with participation from returning […]